Yes, but look at the dates and prices in the S - 1 and the Q.
Knowing what Kay has done in the past,the moriginal warrants were cashed and now they have warrants for 50 million @.05.
But one must remember Kay reduced the original warrants to .02.
S - 1
On September 21, 2021, in conjunction with the Warrant Purchase Agreements, in return for total consideration of $50,000, we issued five-year common stock purchase warrants to purchase up to 50,000,000 shares of restricted common stock to The Special Equities Opportunity Fund, LLC and Gregory Castaldo respectively. . In May 2022, the Company amended the exercise price of 50 million shares of stock warrants granted in September 2021 from $0.05 per share to $0.02 per share. As a result, these warrant holders exercised their warrants and the Company issued 50 million shares of common stock for cash proceeds of $1,000,000. As an inducement to these warrant holders to exercise their warrants, the Company granted them stock warrants to purchase 50 million shares of common stock. The warrants are exercisable at $0.02 per share and will expire in 5 years and the underlying shares have been registered herein. These common stock purchase warrants include a cashless exercise provision if the underlying shares are not timely registered The conversions by the Selling Stockholders are contractually limited such that only 4.99% of the then issued and outstanding shares of our Common Stock may be held by each Selling Stockholder. A condition to nullify the cashless exercise is for the Company to file with the U.S. Securities and Exchange Commission (the "SEC") a registration statement on Form S-1, of which this prospectus is a part.
The Q
On May 5, 2022, we entered into Inducement Offer to Exercise Common Stock Purchase Warrants Letter Agreements (the “Exercise Agreements”) with certain of the holders of the Existing Warrants, The Special Equities Opportunity Fund, LLC and Gregory Castaldo, to purchase an aggregate of 50,000,000 shares of Common Stock (the “Exercising Holders”). Pursuant to the Exercise Agreements, the Exercising Holders and the Company agreed that, subject to any applicable beneficial ownership limitations, the Exercising Holders would exercise their Existing Warrants (the “Investor Warrants”) for shares of Common Stock underlying such Existing Warrants (the “Exercised Shares”) at a reduced exercise price of $0.02 per share of Common Stock. In order to induce the Exercising Holders to cash exercise the Investor Warrants, the Exercise Agreements provide for the issuance of new warrants to purchase up to an aggregate of 50,000,000 shares of Common Stock (the “New Warrants”), with such New Warrants to be issued in an amount equal to the number of the Exercised Shares underlying any Investor Warrants. The New Warrants are exercisable after issuance, provide for a cashless exercise provision if the shares of Common Stock underlying the New Warrants are not registered and terminate on the date that is five years following the issuance of the New Warrants. The New Warrants have an exercise price per share of $0.05. The New Warrants and the shares of Common Stock issuable upon the exercise of the New Warrants are not being registered under the Securities Act of 1933 and are being offered pursuant to the exemption provided in Section 4(a)(2) under the Securities Act of 1933. The Exercised Shares are registered for resale on effective registration statements previously filed with the Securities and Exchange Commission.
